Correlation Between Aerovate Therapeutics and Standard Life

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Standard Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Standard Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Standard Life Aberdeen, you can compare the effects of market volatilities on Aerovate Therapeutics and Standard Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Standard Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Standard Life.

Diversification Opportunities for Aerovate Therapeutics and Standard Life

-0.42

Correlation Coefficient

Aerovate Therapeutics  Standard Life

Very good diversification

The 3 months correlation between Aerovate and Standard is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Standard Life Aberdeen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Standard Life Aberdeen and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Standard Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Standard Life Aberdeen has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Standard Life go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Standard Life

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Standard Life. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.61 times less risky than Standard Life. The stock trades about -0.01 of its potential returns per unit of risk. The Standard Life Aberdeen is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  706.00  in Standard Life Aberdeen on December 23, 2024 and sell it today you would earn a total of  199.00  from holding Standard Life Aberdeen or generate 28.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Standard Life Aberdeen

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Aerovate Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Standard Life Aberdeen

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Standard Life Aberdeen are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Standard Life showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aerovate Therapeutics and Standard Life

The main advantage of trading using opposite Aerovate Therapeutics and Standard Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Standard Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Standard Life will offset losses from the drop in Standard Life's long position.

The idea behind Aerovate Therapeutics and Standard Life Aberdeen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..